Oncternal Therapeutics (ONCT) Q4 2022 Earnings

9MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.24
-0.23
-0.21
-0.2

Details

Expected EPS
-0.21
Actual EPS
-0.2
Surprise EPS
0.01
Surprise Percent
+4.76%

Description

Oncternal Therapeutics (ONCT) has reported earnings of -0.2 per share for Q4 2022.

0 Comments

Share your thoughts